Staff Report to the Mayor and Council Members
Third Public Hearing - Redistricting
January 18, 2022
FISCAL IMPACT
There is no fiscal impact associated with this item.
ALTERNATIVE(S)
1. Provide alternative direction to staff
ATTACHMENT(S)
1. NDC Map 101
2. NDC Map 102
3. NDC Map 103
2 4
1 3
5 Hesperia Golf and Country Club
Hesperia Arprt
San Bernardino Natl Forest
15 15
173
395
138
173
7th Ave
Los
Flor
es Rd
M
uscatel St
E Ave
11th Ave
Lim
e St
Fairburn St
Mesquite St
Joshua St
Phelan Rd
Ranchero Rd
Maple Ave
Topaz Ave
Eucalyptus St
Sycamore St
Cottonwood Ave
M
ojave St
M
esa S
t
Danbury
Ave
Orchid Ave
Preston
St
I Ave
el Cerrito Ave
M
ain
St
Sm
oketree St
Olive St
Sultana
St
Peach Ave
3rd Ave
Hesperia Rd
�2021 CALIPER
Attachment 1
NDC 101
District 1
Total Pop 20,224
Deviation from ideal 191
% Deviation 0.95%
% Hisp 61.3%
% NH White 22%
% NH Black 9%
% Asian-American 5%
Total 10,905
% Hisp 53%
% NH White 33%
% NH Black 8%
% Asian/Pac.Isl. 5%
Total 9,471
% Latino est. 50%
% Spanish-Surnamed 46%
% Asian-Surnamed 3%
% Filipino-Surnamed 1%
% NH White est. 40%
% NH Black 9%
Total 6,665
% Latino est. 47%
% Spanish-Surnamed 43%
% Asian-Surnamed 2%
% Filipino-Surnamed 1%
% NH White est. 42%
% NH Black 9%
Total 3,566
% Latino est. 42%
% Spanish-Surnamed 39%
% Asian-Surnamed 2%
% Filipino-Surnamed 1%
% NH White est. 44%
% NH Black est. 9%
ACS Pop. Est. Total 18,996
age0-19 36%
age20-60 52%
age60plus 12%
immigrants 21%
naturalized 54%
english 65%
spanish 30%
asian-lang 2%
other lang 2%
Language Fluency Speaks Eng. "Less than Very Well" 12%
hs-grad 58%
bachelor 10%
graduatedegree 4%
Child in Household child-under18 55%
Pct of Pop. Age 16+ employed 58%
income 0-25k 13%
income 25-50k 20%
income 50-75k 17%
income 75-200k 47%
income 200k-plus 3%
single family 95%
multi-family 5%
rented 33%
owned 67%
Total population data from the 2020 Decennial Census.
Surname-based Voter Registration and Turnout data from the California Statewide Database.
Latino voter registration and turnout data are Spanish-surname counts adjusted using Census Population Department undercount estimates. NH White and NH Black registration and turnout counts estimated by NDC. Citizen Voting Age Pop., Age, Immigration, and other demographics from the 2015-2019 American Community Survey and Special Tabulation 5-year data.
2 19,504
-529
-2.64%
67%
22%
6%
2%
10,990
57%
36%
4%
3%
8,863
55%
50%
1%
1%
42%
4%
5,819
51%
47%
1%
1%
46%
3%
3,459
41%
39%
1%
1%
52%
3%
18,991
36%
50%
14%
21%
44%
60%
38%
1%
1%
14%
60%
6%
2%
48%
54%
27%
25%
19%
28%
0%
79%
21%
45%
55%
3 20,576
543
2.71%
56%
34%
5%
2%
12,653
46%
46%
4%
2%
10,629
42%
39%
1%
1%
54%
4%
7,476
38%
36%
1%
1%
57%
4%
4,762
30%
29%
1%
1%
63%
4%
20,460
32%
49%
19%
19%
49%
62%
36%
1%
1%
12%
57%
8%
5%
44%
55%
31%
23%
18%
26%
2%
89%
11%
38%
62%
4 20,598
565
2.82%
61%
30%
4%
2%
11,505
51%
42%
4%
3%
10,127
45%
42%
1%
1%
52%
3%
7,301
41%
38%
1%
1%
55%
3%
4,441
32%
30%
0%
0%
63%
3%
18,703
31%
52%
17%
20%
48%
63%
35%
1%
1%
15%
59%
6%
3%
44%
58%
21%
25%
21%
31%
1%
88%
12%
40%
60%
5 19,264
-769
-3.84%
49%
40%
6%
2%
11,344
38%
54%
6%
2%
10,476
35%
33%
1%
1%
59%
5%
7,749
31%
29%
1%
1%
63%
5%
4,857
25%
24%
1%
1%
67%
5%
17,644
31%
53%
16%
12%
49%
83%
16%
1%
0%
7%
64%
8%
5%
41%
57%
18%
24%
23%
32%
4%
88%
12%
36%
64%
Total
100,166
1,334
6.66%
59%
29%
6%
3%
57,397
49%
42%
5%
3%
49,566
45%
41%
1%
1%
50%
5%
35,010
41%
38%
1%
1%
53%
5%
21,085
33%
32%
1%
1%
59%
5%
94,795
33%
51%
16%
19%
49%
66%
31%
1%
1%
12%
59%
7%
4%
46%
56%
22%
24%
20%
32%
2%
88%
12%
38%
62%
01/09/2022 14:53 Page 1 of 1
Total Pop
Citizen Voting Age Pop
Voter Registration
(Nov 2020)
Voter Turnout
(Nov 2020)
Voter Turnout
(Nov 2018)
Age
Immigration
Language spoken at home
Education
(among those age 25+)
Household Income
Housing Stats
2 3
1 4
5 Hesperia Golf and Country Club
Hesperia Arprt
San Bernardino Natl Forest
15 15
173
395
138
173
7th Ave
Los
Flor
es Rd
M
uscatel St
E Ave
11th Ave
Lim
e St
Fairburn St
el Centro St
Mesquite St
Joshua St
Phelan Rd
Yu
cca Terrace Dr
Ranchero Rd
Maple Ave
Topaz Ave
Balsam Ave
Eucalyptus St
Sycamore St
Cottonwood Ave
M
ojave St
M
esa S
t
Choiceana Ave
Orchid Ave
Preston
St
I Ave
Jenkins Ave
el Cerrito Ave
M
ain
St
Olive St
Sultana
St
Peach Ave
3rd Ave
Hesperia Rd
�2021 CALIPER
Attachment 2
NDC 102
District 1
Total Pop 20,242
Deviation from ideal 209
% Deviation 1.04%
% Hisp 64.1%
% NH White 24%
% NH Black 6%
% Asian-American 3%
Total 11,518
% Hisp 57%
% NH White 35%
% NH Black 5%
% Asian/Pac.Isl. 2%
Total 9,358
% Latino est. 52%
% Spanish-Surnamed 48%
% Asian-Surnamed 1%
% Filipino-Surnamed 1%
% NH White est. 44%
% NH Black 5%
Total 6,414
% Latino est. 48%
% Spanish-Surnamed 45%
% Asian-Surnamed 1%
% Filipino-Surnamed 1%
% NH White est. 46%
% NH Black 5%
Total 3,782
% Latino est. 38%
% Spanish-Surnamed 36%
% Asian-Surnamed 1%
% Filipino-Surnamed 1%
% NH White est. 54%
% NH Black est. 4%
ACS Pop. Est. Total 19,516
age0-19 36%
age20-60 49%
age60plus 15%
immigrants 20%
naturalized 49%
english 62%
spanish 36%
asian-lang 1%
other lang 0%
Language Fluency Speaks Eng. "Less than Very Well" 14%
hs-grad 61%
bachelor 6%
graduatedegree 2%
Child in Household child-under18 49%
Pct of Pop. Age 16+ employed 53%
income 0-25k 25%
income 25-50k 23%
income 50-75k 22%
income 75-200k 29%
income 200k-plus 0%
single family 84%
multi-family 16%
rented 42%
owned 58%
Total population data from the 2020 Decennial Census.
Surname-based Voter Registration and Turnout data from the California Statewide Database.
Latino voter registration and turnout data are Spanish-surname counts adjusted using Census Population Department undercount estimates. NH White and NH Black registration and turnout counts estimated by NDC. Citizen Voting Age Pop., Age, Immigration, and other demographics from the 2015-2019 American Community Survey and Special Tabulation 5-year data.
2 20,012
-21
-0.10%
64%
23%
9%
2%
11,027
52%
35%
7%
2%
8,282
50%
46%
1%
1%
42%
9%
5,315
46%
43%
0%
1%
45%
8%
3,061
39%
38%
0%
1%
50%
8%
19,762
35%
52%
14%
20%
36%
60%
39%
1%
1%
13%
57%
6%
3%
46%
57%
33%
27%
15%
25%
0%
68%
32%
58%
42%
3 20,165
132
0.66%
53%
37%
4%
2%
12,459
42%
52%
3%
2%
10,890
39%
36%
1%
1%
58%
3%
7,792
35%
33%
1%
1%
61%
3%
4,971
28%
27%
1%
1%
67%
2%
19,695
32%
50%
18%
17%
51%
68%
30%
1%
1%
11%
58%
9%
5%
42%
57%
26%
25%
19%
26%
3%
92%
8%
35%
65%
4 20,035
2 0.01%
61%
23%
8%
5%
10,462
54%
34%
6%
5%
9,936
49%
45%
3%
1%
43%
7%
7,085
46%
42%
2%
1%
45%
7%
3,960
39%
36%
2%
1%
51%
7%
17,944
34%
51%
14%
21%
54%
65%
30%
3%
3%
12%
57%
10%
4%
51%
59%
11%
18%
19%
48%
3%
97%
3%
30%
70%
5 19,712
-321
-1.60%
51%
40%
3%
2%
11,932
40%
53%
5%
2%
11,100
37%
35%
1%
1%
59%
4%
8,404
34%
32%
1%
1%
62%
3%
5,311
26%
25%
1%
0%
67%
4%
17,877
29%
53%
18%
15%
57%
78%
21%
1%
0%
8%
64%
5%
5%
43%
57%
14%
24%
23%
36%
3%
99%
1%
26%
74%
Total
100,166
530
2.65%
59%
29%
6%
3%
57,397
49%
42%
5%
3%
49,566
45%
41%
1%
1%
50%
5%
35,010
41%
38%
1%
1%
53%
5%
21,085
33%
32%
1%
1%
59%
5%
94,795
33%
51%
16%
19%
49%
66%
31%
1%
1%
12%
59%
7%
4%
46%
56%
22%
24%
20%
32%
2%
88%
12%
38%
62%
01/09/2022 15:03 Page 1 of 1
Total Pop
Citizen Voting Age Pop
Voter Registration
(Nov 2020)
Voter Turnout
(Nov 2020)
Voter Turnout
(Nov 2018)
Age
Immigration
Language spoken at home
Education
(among those age 25+)
Household Income
Housing Stats
2 4
3 1
5 Hesperia Golf and Country Club
Hesperia Arprt
San Bernardino Natl Forest
15 15
173
395
138
173
7th Ave
Los
Flor
es Rd
M
uscatel St
E Ave
11th Ave
Lim
e St
Fairburn St
el Centro St
Mesquite St
Joshua St
Phelan Rd
Yu
cca Terrace Dr
Ranchero Rd
Maple Ave
Topaz Ave
Balsam Ave
Eucalyptus St
Sycamore St
Cottonwood Ave
M
ojave St
M
esa S
t
Danbury
Ave
Orchid Ave
Preston
St
I Ave
Jenkins Ave
el Cerrito Ave
M
ain
St
Sm
oketree St
Olive St
Sultana
St
Peach Ave
3rd Ave
Hesperia Rd
�2021 CALIPER
Attachment 3
NDC 103
District 1
Total Pop 20,381
Deviation from ideal 348
% Deviation 1.74%
% Hisp 63.0%
% NH White 22%
% NH Black 8%
% Asian-American 4%
Total 11,069
% Hisp 57%
% NH White 34%
% NH Black 5%
% Asian/Pac.Isl. 3%
Total 9,705
% Latino est. 51%
% Spanish-Surnamed 47%
% Asian-Surnamed 2%
% Filipino-Surnamed 1%
% NH White est. 43%
% NH Black 6%
Total 6,850
% Latino est. 47%
% Spanish-Surnamed 44%
% Asian-Surnamed 2%
% Filipino-Surnamed 1%
% NH White est. 44%
% NH Black 6%
Total 3,807
% Latino est. 41%
% Spanish-Surnamed 38%
% Asian-Surnamed 1%
% Filipino-Surnamed 1%
% NH White est. 49%
% NH Black est. 6%
ACS Pop. Est. Total 19,146
age0-19 36%
age20-60 50%
age60plus 14%
immigrants 21%
naturalized 52%
english 64%
spanish 33%
asian-lang 2%
other lang 1%
Language Fluency Speaks Eng. "Less than Very Well" 12%
hs-grad 59%
bachelor 8%
graduatedegree 4%
Child in Household child-under18 53%
Pct of Pop. Age 16+ employed 56%
income 0-25k 18%
income 25-50k 19%
income 50-75k 18%
income 75-200k 44%
income 200k-plus 1%
single family 93%
multi-family 7%
rented 32%
owned 68%
Total population data from the 2020 Decennial Census.
Surname-based Voter Registration and Turnout data from the California Statewide Database.
Latino voter registration and turnout data are Spanish-surname counts adjusted using Census Population Department undercount estimates. NH White and NH Black registration and turnout counts estimated by NDC. Citizen Voting Age Pop., Age, Immigration, and other demographics from the 2015-2019 American Community Survey and Special Tabulation 5-year data.
2 19,815
-218
-1.09%
67%
22%
6%
2%
10,954
56%
36%
4%
3%
8,535
55%
50%
1%
1%
42%
4%
5,508
51%
47%
1%
1%
45%
4%
3,164
42%
40%
1%
1%
51%
3%
19,280
35%
52%
14%
21%
38%
58%
40%
1%
1%
15%
59%
5%
2%
48%
56%
28%
27%
18%
27%
1%
75%
25%
51%
49%
3 19,797
-236
-1.18%
57%
31%
7%
2%
11,434
48%
41%
7%
2%
9,654
43%
40%
1%
1%
51%
7%
6,675
40%
37%
0%
1%
53%
7%
4,138
32%
30%
1%
0%
59%
7%
18,641
31%
51%
18%
18%
45%
64%
34%
1%
1%
11%
59%
7%
4%
41%
55%
32%
23%
17%
26%
2%
78%
22%
47%
53%
4 20,338
305
1.52%
58%
31%
4%
4%
11,506
47%
42%
6%
5%
10,349
44%
41%
2%
1%
50%
5%
7,528
41%
38%
1%
1%
53%
5%
4,562
32%
30%
1%
0%
60%
5%
18,435
32%
52%
17%
20%
57%
67%
30%
2%
2%
13%
60%
8%
4%
45%
58%
16%
25%
21%
36%
2%
95%
5%
34%
66%
5 19,835
-198
-0.99%
48%
43%
4%
2%
12,435
37%
57%
3%
1%
11,323
35%
33%
1%
1%
62%
2%
8,449
31%
29%
1%
1%
65%
3%
5,414
24%
23%
1%
1%
70%
3%
19,293
32%
51%
17%
13%
55%
79%
20%
1%
0%
9%
61%
8%
5%
44%
57%
18%
24%
23%
31%
4%
98%
2%
28%
72%
Total
100,166
584
2.92%
59%
29%
6%
3%
57,397
49%
42%
5%
3%
49,566
45%
41%
1%
1%
50%
5%
35,010
41%
38%
1%
1%
53%
5%
21,085
33%
32%
1%
1%
59%
5%
94,795
33%
51%
16%
19%
49%
66%
31%
1%
1%
12%
59%
7%
4%
46%
56%
22%
24%
20%
32%
2%
88%
12%
38%
62%
01/09/2022 15:16 Page 1 of 1
Total Pop
Citizen Voting Age Pop
Voter Registration
(Nov 2020)
Voter Turnout
(Nov 2020)
Voter Turnout
(Nov 2018)
Age
Immigration
Language spoken at home
Education
(among those age 25+)
Household Income
Housing Stats
01071.0001/760959.1
City of Hesperia
STAFF REPORT
DATE: January 18, 2022
TO: Mayor and Council Members
FROM: Nils Bentsen, City Manager
BY: Eric L. Dunn, City Attorney
SUBJECT: National Opioid Settlements – Permitted Use of Settlement Funds
RECOMMENDED ACTION
It is recommended that the City Council receive and file this report.
BACKGROUND
On December 21, 2021, the City Council approved participation in the National Opioid Settlements. By way of providing background, v arious states, counties, and cities have been in litigation with the McKesson Corporation, Cardinal Health, Inc., and AmerisourceBergen Corporation. (collectively, the “Distributors”) and Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica, Inc. (collectively, the “Manufacturer”) (for purposes of this report, the Distributors and Manufacturer are collectively referred to as the “Settling Defendants”).
The litigation concerns the distribution and manufacture of opioids that have contributed to the opioid addiction epidemic in the United States. Two tentative settlements have been reached with the Distributors and Manufacturer, respectively (“National Opioids Settlements”). The full text of the National Opioid Settlements can be found at the following website under the links entitled “Distributor Master Settlement Agreement” and “J&J Master Settlement Agreement”:
https://nationalopioidsettlement.com. This website also contains additional detailed information regarding the National Opioid Settlements.
In order to proceed, a “critical mass” of participation by States, cities and counties must be achieved. This critical mass is determined by the Settling Defendants in their sole discretion. If a critical mass is not achieved, then the National Opioids Settlements do not proceed and the litigation continues. Thus, there a re two parts to achieving critical mass: first, a critical mass of States must be achieved and, second, a critical mass of cities and counties must be achieved. At this stage, a critical mass of state participation has already occurred. By participating, t he City has contributed to the “critical mass” of cities and counties.
ISSUES/ANALYSIS
Assuming there is a critical mass to proceed, the payout amounts under the settlements with the Settling Defendants is contingent upon various factors, including the number of states, cities, and counties participating, with a maximum payout of $21 billion over the course of 18 years by the Distributors and $5 billion over no more than nine years by the Manufacturer to all participating entities. A fraction of that amount will be received by California, its counties, and cities. The actual
Staff Report to the Mayor and Council Members
National Opioid Settlements – Permitted Use of Settlement Funds January 18, 2021
01071.0001/760959.1
amount for the Ci ty is dependent on a number of variables, including, but not limited to, the number of California cities and counties participating (essentially, the more cities and counties in California participating means more money that could be allocated to the City) , whether or not cities later sue the Settling Defendants, and certain actions that may be taken by the State of California. Further, the City’s share of the potential amount is determined using three factors: (1) Opioid use disorder; (2) Opioid deaths; and (3) Opioid dosage.
The funds will automatically be allocated to the County unless the City opts to receive the funds directly; however, there are certain reporting and tracking requirements if the City receives the funds directly (see below). If the County receives the City’s share of the settlement funds per the Agreements, the County is not required to exclusively spend the funds in the City (however, it should also be noted that funds will probably be used on County programs that are available to all residents of the County). Additionally, the City may opt in and out of receiving the funds directly at any time, provided that this is communicated to the Settlement Fund Administrator at least 60 days prior to a payment date. For example, the City may opt to send the funds to the County for 2022 but may later decide that the 2023 allocation be directly received by the City. At this point in time, there is currently no process set-up for the City to opt to receive the funds directly; however, we have been informed that, if the settlement proceeds and once a settlement fund administrator is chosen, then a procedure will be created.
The National Opioid Settlements will allow for a range of approved abatement uses, which includes a range of intervention, treatment, education, and recovery services. However, the use of funds is restricted to the opioid abatement remediation activities . Attachment 1 of this Report includes the permissible uses for settlement funds. The uses potentially include utilizing the settlements funds to partner with a local nonprofit regarding opioid remediation. For example, on the City may support people with op ioid use disorder through evidence-based and evidenced - informed programs or strategies that include programs or strategies that “ Engage non-profits, faith-based communities, and community coalitions to support people in treatment and recovery and to support family members in their efforts to support the person with OUD in the family.” (See Page E -5 and E -6 of Attachment 1) (“OUD” stands for “opioid use disorder” per the master settlement agreements).
Additionally, 50% of the settlement funds per calendar year must be spent on “high impact abatement activities” as follows:
“In addition to this requirement, no less than 50% of the funds received by a CA Participating Subdivision [i.e., cities and counties] from the Abatement Accounts Fund in each calendar year will be used for one or more of the following High Impact Abatement Activities:
(1) the provision of matching funds or operating costs for substance use disorder facilities within the Behavioral Health Continuum Infrastructure Program; (2) creating new or expanded Substance Use Disorder (“SUD”) treatment infrastructure; (3) addressing the needs of communities of color and vulnerable populations (including sheltered and unsheltered homeless populations) that are disproportionately impacted by SUD;
(4) di version of people with SUD from the justice system into treatment, including by providing training and resources to first and early responders (sworn and non-sworn) and implementing best practices for outreach, diversion and deflection, employability, restorative justice, and harm reduction; and/or
(5) interventions to prevent drug addiction in vulnerable youth”
Staff Report to the Mayor and Council Members
National Opioid Settlements – Permitted Use of Settlement Funds January 18, 2021
01071.0001/760959.1
The California Department of Health Care Services (“DHCS”) may add to this list (but not delete from it) by designating additional High Impact Aba tement Activities. DHCS is also required to make reasonable efforts to consult with stakeholders, including the CA Participating Subdivisions, before adding additional High Impact Abatement Activities to this list.
There are also significant public reporting and tracking requirements on the expenditures for such funds, which may make County receipt and expenditure of such funds more desirable. For example, the State-Subdivision Allocation agreements for the Manufacturer and Distributors would require the following reporting and tracking:
1. Each CA Participating Subdivision (i.e., cities and counties) that receives payments of funds from the settlement must prepare written reports at least annually regarding the use of those funds, until those funds are fully expended and for one year thereafter. These reports will also include a certification that all funds received through the settlement have been used in compliance with the settlement agreements and the allocation agreements. The report will be in a form reasonably determined by DHCS.
2. All CA Participating Subdivisions receiving CA Abatement Accounts Funds must track all deposits and expenditures. Each such subdivision is responsible solely for the settlement fu nds it receives. However, a county is not responsible for oversight, reporting, or monitoring of settlement funds received by a city within that county that receives direct payment. Unless otherwise exempt, expenditures and uses of settlement funds will be subject to the normal budgetary and expenditure process of the relevant subdivision.
In terms of enforcement, if DHCS believes that the use of settlement funds is inconsistent with the requirements, it must meet and confer with the subdivision (i.e., the City), and if not resolved, DHCS may perform an audit. If the issue is not resolved, DHCS can bring a motion or action in court to resolve the concern or to enforce the terms of the settlement agreement/state-allocation agreement. There are also time limits on expenditure where money not expended or encumbered within 5 years of receipt must be transferred to the State. However, these requirements only apply to the City if it elects to receive direct distribution and does not apply to the City if the funds go to the County.
FISCAL IMPACT
It is estimated that Hesperia’s total share is $560,985 or approximately $31,165 per year over 18 years. This figure assumes 100% participation by cities and counties, a decrease of which will decrease the actual amount.
ALTERNATIVE(S)
1. Provide alternative direction to staff
ATTACHMENT(S)
Attachment 1 – Exhibit E of the Master Settlement Agreements
E-1
EXHIBIT E
L
ist of Opioid Remediation Uses
Schedule A
Core Strategies
States and Qualifying Block Grantees shall choose from among the abatement strategies listed in Core
Strategies 14
A. NALOXONE OR OTHER FDA-APPROVED DRUG TO
REVERSE OPIOID OVERDOSES
1. Expand training for first responders, schools, community support groups and families; and
2. Increase distribution to individuals who are uninsured or whose insurance does not cover the needed service.
B. MEDICATION-
MAT
DISTRIBUTION AND OTHER OPIOID-RELATED
TREATMENT
1. Increase distribution of MAT to individuals who are
uninsured or whose insurance does not cover the needed
service;
2. Provide education to school-based and youth-focused
programs that discourage or prevent misuse;
3. Provide MAT education and awareness training to
healthcare providers, EMTs, law enforcement, and other
first responders; and
4. Provide treatment and recovery support services such as residential and inpatient treatment, intensive outpatient treatment, outpatient therapy or counseling, and recovery housing that allow or integrate medication and with other support services.
14 rence for
new or existing programs.
E-2
C. PREGNANT & POSTPARTUM WOMEN
1. Expand Screening, Brief Intervention, and Referral to SBIRT -Medicaid eligible or
uninsured pregnant women;
2. Expand comprehensive evidence-based treatment and
recovery services, including MAT, for women with co-
OUD
SUD
for uninsured individuals for up to 12 months postpartum; and
3. Provide comprehensive wrap-around services to individuals with OUD, including housing, transportation, job
placement/training, and childcare.
D. EXPANDING TREATMENT FOR NEONATAL
NAS
1. Expand comprehensive evidence-based and recovery
support for NAS babies;
2. Expand services for better continuum of care with infant- need dyad; and
3. Expand long-term treatment and services for medical
monitoring of NAS babies and their families.
E. EXPANSION OF WARM HAND-OFF PROGRAMS AND
RECOVERY SERVICES
1. Expand services such as navigators and on-call teams to begin MAT in hospital emergency departments;
2. Expand warm hand-off services to transition to recovery services;
3. Broaden scope of recovery services to include co-occurring SUD or mental health conditions;
4. Provide comprehensive wrap-around services to individuals in recovery, including housing, transportation, job
placement/training, and childcare; and
5. Hire additional social workers or other behavioral health workers to facilitate expansions above.
E-3
F. TREATMENT FOR INCARCERATED POPULATION
1. Provide evidence-based treatment and recovery support, including MAT for persons with OUD and co-occurring
SUD/MH disorders within and transitioning out of the
criminal justice system; and
2. Increase funding for jails to provide treatment to inmates with OUD.
G. PREVENTION PROGRAMS
1. Funding for media campaigns to prevent opioid use (similar misusing tobacco);
2. Funding for evidence-based prevention programs in
schools;
3. Funding for medical provider education and outreach
regarding best prescribing practices for opioids consistent with the 2016 CDC guidelines, including providers at
hospitals (academic detailing);
4. Funding for community drug disposal programs; and
5. Funding and training for first responders to participate in pre-arrest diversion programs, post-overdose response
teams, or similar strategies that connect at-risk individuals to behavioral health services and supports.
H. EXPANDING SYRINGE SERVICE PROGRAMS
1. Provide comprehensive syringe services programs with more wrap-around services, including linkage to OUD
treatment, access to sterile syringes and linkage to care and treatment of infectious diseases.
I. EVIDENCE-BASED DATA COLLECTION AND
RESEARCH ANALYZING THE EFFECTIVENESS OF THE
ABATEMENT STRATEGIES WITHIN THE STATE
E-4
Schedule B
Approved Uses
Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use Disorder or Mental Health (SUD/MH) conditions through evidence-based or evidence-informed programs or strategies that may include, but are not limited to, the following:
PART ONE: TREATMENT
A. T
REAT OPIOID USE DISORDER (OUD)
OUD -occurring Substance Use
SUD/MH itions through evidence-based or evidence-
informed programs or strategies that may include, but are not limited to, those that: 15
1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions, including all forms of Medication-Assisted MAT approved by the U.S. Food and Drug Administration.
2. Support and reimburse evidence-based services that adhere to the American ASAM -
occurring SUD/MH conditions.
3. Expand telehealth to increase access to treatment for OUD and any co-occurring SUD/MH conditions, including MAT, as well as counseling, psychiatric support, and other treatment and recovery support services.
4. OTPs to assure evidence-
based or evidence-informed practices such as adequate methadone dosing and low threshold approaches to treatment.
5. Support mobile intervention, treatment, and recovery services, offered by qualified professionals and service providers, such as peer recovery coaches, for persons with OUD and any co-occurring SUD/MH conditions and for persons who have experienced an opioid overdose.
6. Provide treatment of trauma for individuals with OUD (e.g., violence, sexual assault, human trafficking, or adverse childhood experiences) and family members (e.g., surviving family members after an overdose or overdose fatality), and training of health care personnel to identify and address such trauma.
7. Support evidence-based withdrawal management services for people with OUD and any co-occurring mental health conditions.
15 new or existing programs.
E-5
8. Provide training on MAT for health care providers, first responders, students, or other supporting professionals, such as peer recovery coaches or recovery outreach specialists, including telementoring to assist community-based providers in rural or underserved areas.
9. Support workforce development for addiction professionals who work with persons with OUD and any co-occurring SUD/MH conditions.
10. Offer fellowships for addiction medicine specialists for direct patient care, instructors, and clinical research for treatments.
11. Offer scholarships and supports for behavioral health practitioners or workers involved in addressing OUD and any co-occurring SUD/MH or mental health conditions, including, but not limited to, training, scholarships, fellowships, loan repayment programs, or other incentives for providers to work in rural or underserved areas.
12. Provide funding and training for clinicians to obtain a waiver under the federal Drug Addiction Treatment
DATA 2000
OUD, and provide technical assistance and professional support to clinicians who have obtained a DATA 2000 waiver.
13. Disseminate of web-based training curricula, such as the American Academy of Addiction Psychia
Opioids web-based
training curriculum and motivational interviewing.
14. Develop and disseminate new curricula, such as the American Academy of Assisted Treatment.
B. SUPPORT PEOPLE IN TREATMENT AND RECOVERY
Support people in recovery from OUD and any co-occurring SUD/MH conditions through evidence-based or evidence-informed programs or strategies that may include, but are not limited to, the programs or strategies that:
1. Provide comprehensive wrap-around services to individuals with OUD and any co-occurring SUD/MH conditions, including housing, transportation, education, job placement, job training, or childcare.
2. Provide the full continuum of care of treatment and recovery services for OUD and any co-occurring SUD/MH conditions, including supportive housing, peer support services and counseling, community navigators, case management, and connections to community-based services.
3. Provide counseling, peer-support, recovery case management and residential treatment with access to medications for those who need it to persons with OUD and any co-occurring SUD/MH conditions.
E-6
4. Provide access to housing for people with OUD and any co-occurring SUD/MH conditions, including supportive housing, recovery housing, housing assistance programs, training for housing providers, or recovery housing programs that allow or integrate FDA-approved mediation with other support services.
5. Provide community support services, including social and legal services, to assist in deinstitutionalizing persons with OUD and any co-occurring SUD/MH conditions.
6. Support or expand peer-recovery centers, which may include support groups, social events, computer access, or other services for persons with OUD and any co-occurring SUD/MH conditions.
7. Provide or support transportation to treatment or recovery programs or services for persons with OUD and any co-occurring SUD/MH conditions.
8. Provide employment training or educational services for persons in treatment for or recovery from OUD and any co-occurring SUD/MH conditions.
9. Identify successful recovery programs such as physician, pilot, and college recovery programs, and provide support and technical assistance to increase the number and capacity of high-quality programs to help those in recovery.
10. Engage non-profits, faith-based communities, and community coalitions to support people in treatment and recovery and to support family members in their efforts to support the person with OUD in the family.
11. Provide training and development of procedures for government staff to appropriately interact and provide social and other services to individuals with or in recovery from OUD, including reducing stigma.
12. Support stigma reduction efforts regarding treatment and support for persons with OUD, including reducing the stigma on effective treatment.
13. Create or support culturally appropriate services and programs for persons with OUD and any co-occurring SUD/MH conditions, including new Americans.
14. Create and/or support recovery high schools.
15. Hire or train behavioral health workers to provide or expand any of the services or supports listed above.
C. CONNECT PEOPLE WHO NEED HELP TO THE HELP THEY NEED
(CONNECTIONS TO CARE)
Provide connections to care for people who have or are at risk of developing OUD and any co-occurring SUD/MH conditions through evidence-based or evidence-informed programs or strategies that may include, but are not limited to, those that:
E-7
1. Ensure that health care providers are screening for OUD and other risk factors and know how to appropriately counsel and treat (or refer if necessary) a patient for OUD treatment.
2. Fund SBIRT programs to reduce the transition from use to disorders, including SBIRT services to pregnant women who are uninsured or not eligible for Medicaid.
3. Provide training and long-term implementation of SBIRT in key systems (health, schools, colleges, criminal justice, and probation), with a focus on youth and young adults when transition from misuse to opioid disorder is common.
4. Purchase automated versions of SBIRT and support ongoing costs of the technology.
5. Expand services such as navigators and on-call teams to begin MAT in hospital emergency departments.
6. Provide training for emergency room personnel treating opioid overdose patients on post-discharge planning, including community referrals for MAT, recovery case management or support services.
7. Support hospital programs that transition persons with OUD and any co-occurring SUD/MH conditions, or persons who have experienced an opioid overdose, into clinically appropriate follow-up care through a bridge clinic or similar approach.
8. Support crisis stabilization centers that serve as an alternative to hospital emergency departments for persons with OUD and any co-occurring SUD/MH conditions or persons that have experienced an opioid overdose.
9. Support the work of Emergency Medical Systems, including peer support specialists, to connect individuals to treatment or other appropriate services following an opioid overdose or other opioid-related adverse event.
10. Provide funding for peer support specialists or recovery coaches in emergency departments, detox facilities, recovery centers, recovery housing, or similar settings; offer services, supports, or connections to care to persons with OUD and any co-occurring SUD/MH conditions or to persons who have experienced an opioid overdose.
11. Expand warm hand-off services to transition to recovery services.
12. Create or support school-based contacts that parents can engage with to seek immediate treatment services for their child; and support prevention, intervention, treatment, and recovery programs focused on young people.
13. Develop and support best practices on addressing OUD in the workplace.
E-8
14. Support assistance programs for health care providers with OUD.
15. Engage non-profits and the faith community as a system to support outreach for treatment.
16. Support centralized call centers that provide information and connections to appropriate services and supports for persons with OUD and any co-occurring SUD/MH conditions.
D. ADDRESS THE NEEDS OF CRIMINAL JUSTICE-INVOLVED PERSONS Address the needs of persons with OUD and any co-occurring SUD/MH conditions who are involved in, are at risk of becoming involved in, or are transitioning out of the criminal justice system through evidence-based or evidence-informed programs or strategies that may include, but are not limited to, those that:
1. Support pre-arrest or pre-arraignment diversion and deflection strategies for persons with OUD and any co-occurring SUD/MH conditions, including established strategies such as:
1. Self-referral strategies such as the Angel Programs or the Police Assisted PAARI
2. Ac
tive outreach strategies such as the Drug Abuse Response Team DART
3. have received naloxone to reverse the effects of an overdose are then linked to treatment programs or other appropriate services;
4. Officer prevention strategies, such as the Law Enforcement Assisted LEAD
5. Offi
cer intervention strategies such as the Leon County, Florida Adult Civil Citation Network or the Chicago Westside Narcotics Diversion to Treatment Initiative; or
6. Co-responder and/or alternative responder models to address OUD-related 911 calls with greater SUD expertise.
2. Support pre-trial services that connect individuals with OUD and any co- occurring SUD/MH conditions to evidence-informed treatment, including MAT, and related services.
3. Support treatment and recovery courts that provide evidence-based options for persons with OUD and any co-occurring SUD/MH conditions.
E-9
4. Provide evidence-informed treatment, including MAT, recovery support, harm reduction, or other appropriate services to individuals with OUD and any co- occurring SUD/MH conditions who are incarcerated in jail or prison.
5. Provide evidence-informed treatment, including MAT, recovery support, harm reduction, or other appropriate services to individuals with OUD and any co- occurring SUD/MH conditions who are leaving jail or prison or have recently left jail or prison, are on probation or parole, are under community corrections supervision, or are in re-entry programs or facilities.
6. CTI
dual-diagnosis OUD/serious mental illness, and services for individuals who face immediate risks and service needs and risks upon release from correctional settings.
7. Provide training on best practices for addressing the needs of criminal justice- involved persons with OUD and any co-occurring SUD/MH conditions to law enforcement, correctional, or judicial personnel or to providers of treatment, recovery, harm reduction, case management, or other services offered in connection with any of the strategies described in this section.
E. ADDRESS THE NEEDS OF PREGNANT OR PARENTING WOMEN AND
THEIR FAMILIES, INCLUDING BABIES WITH NEONATAL ABSTINENCE
SYNDROME
Address the needs of pregnant or parenting women with OUD and any co-occurring SUD/MH conditions, and the needs of their families, including babies with neonatal NAS -based or evidence-informed programs
or strategies that may include, but are not limited to, those that:
1. Support evidence-based or evidence-informed treatment, including MAT, recovery services and supports, and prevention services for pregnant women or wom
en who could become pregnant who have OUD and any co-occurring SUD/MH conditions, and other measures to educate and provide support to families affected by Neonatal Abstinence Syndrome.
2. Expand comprehensive evidence-based treatment and recovery services, including MAT, for uninsured women with OUD and any co-occurring SUD/MH conditions for up to 12 months postpartum.
3. Provide training for obstetricians or other healthcare personnel who work with pregnant women and their families regarding treatment of OUD and any co- occurring SUD/MH conditions.
4. Expand comprehensive evidence-based treatment and recovery support for NAS babies; expand services for better continuum of care with infant-need dyad; and expand long-term treatment and services for medical monitoring of NAS babies and their families.
E-10
5. Provide training to health care providers who work with pregnant or parenting women on best practices for compliance with federal requirements that children born with NAS get referred to appropriate services and receive a plan of safe care.
6. Provide child and family supports for parenting women with OUD and any co- occurring SUD/MH conditions.
7. Provide enhanced family support and child care services for parents with OUD and any co-occurring SUD/MH conditions.
8. Provide enhanced support for children and family members suffering trauma as a result of addiction in the family; and offer trauma-informed behavioral health treatment for adverse childhood events.
9. Offer home-based wrap-around services to persons with OUD and any co- occurring SUD/MH conditions, including, but not limited to, parent skills training.
10. Fund additional positions and services,
including supportive housing and other residential services, relating to children being removed from the home and/or placed in foster care due to custodial opioid use.
PART TWO: PREVENTION
F. PREVENT OVER-PRESCRIBING AND ENSURE APPROPRIATE
PRESCRIBING AND DISPENSING OF OPIOIDS
Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing of opioids through evidence-based or evidence-informed programs or strategies that may include, but are not limited to, the following:
1. Funding medical provider education and outreach regarding best prescribing practices for opioids consistent with the Guidelines for Prescribing Opioids for Chronic Pain from the U.S. Centers for Disease Control and Prevention, including providers at hospitals (academic detailing).
2. Training for health care providers regarding safe and responsible opioid prescribing, dosing, and tapering patients off opioids.
3. Continuing Medical Education (CME) on appropriate prescribing of opioids.
4. Providing Support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain.
5. Supporting enhancements or improvements to Prescription Drug Monitoring PDMPs , but not limited to, improvements that:
E-11
1. Increase the number of prescribers using PDMPs;
2. Improve point-of-care decision-making by increasing the quantity, quality, or format of data available to prescribers using PDMPs, by improving the interface that prescribers use to access PDMP data, or both; or
3. Enable states to use PDMP data in support of surveillance or intervention strategies, including MAT referrals and follow-up for individuals identified within PDMP data as likely to experience OUD in a manner that complies with all relevant privacy and security laws and rules.
6. Ensuring PDMPs incorporate available overdose/naloxone deployment data, Technician overdose database in a manner that complies with all relevant privacy and security laws and rules.
7. Increasing electronic prescribing to prevent diversion or forgery.
8. Educating dispensers on appropriate opioid dispensing.
G. PREVENT MISUSE OF OPIOIDS
Support efforts to discourage or prevent misuse of opioids through evidence-based or evidence-informed programs or strategies that may include, but are not limited to, the following:
1. Funding media campaigns to prevent opioid misuse.
2. Corrective advertising or affirmative public education campaigns based on evidence.
3. Public education relating to drug disposal.
4. Drug take-back disposal or destruction programs.
5. Funding community anti-drug coalitions that engage in drug prevention efforts.
6. Supporting community coalitions in implementing evidence-informed prevention, such as reduced social access and physical access, stigma reduction including
staffing, educational campaigns, support for people in treatment or recovery, or training of coalitions in evidence-informed implementation, including the Strategic Prevention Framework developed by the U.S. Substance Abuse and SAMHSA
7. E
ngaging non-profits and faith-based communities as systems to support prevention.
E-12
8. Funding evidence-based prevention programs in schools or evidence-informed school and community education programs and campaigns for students, families, school employees, school athletic programs, parent-teacher and student associations, and others.
9. School-based or youth-focused programs or strategies that have demonstrated effectiveness in preventing drug misuse and seem likely to be effective in preventing the uptake and use of opioids.
10. Create or support community-based education or intervention services for families, youth, and adolescents at risk for OUD and any co-occurring SUD/MH conditions.
11. Support evidence-informed programs or curricula to address mental health needs of young people who may be at risk of misusing opioids or other drugs, including emotional modulation and resilience skills.
12. Support greater access to mental health services and supports for young people, including services and supports provided by school nurses, behavioral health workers or other school staff, to address mental health needs in young people that (when not properly addressed) increase the risk of opioid or another drug misuse.
H. PREVENT OVERDOSE DEATHS AND OTHER HARMS (HARM REDUCTION) Support efforts to prevent or reduce overdose deaths or other opioid-related harms through evidence-based or evidence-informed programs or strategies that may include, but are not limited to, the following:
1. Increased availability and distribution of naloxone and other drugs that treat overdoses for first responders, overdose patients, individuals with OUD and their friends and family members, schools, community navigators and outreach workers, persons being released from jail or prison, or other members of the general public.
2. Public health entities providing free naloxone to anyone in the community.
3. Training and education regarding naloxone and other drugs that treat overdoses for first responders, overdose patients, patients taking opioids, families, schools, community support groups, and other members of the general public.
4. Enabling school nurses and other school staff to respond to opioid overdoses, and provide them with naloxone, training, and support.
5. Expanding, improving, or developing data tracking software and applications for overdoses/naloxone revivals.
6. Public education relating to emergency responses to overdoses.
E-13
7. Public education relating to immunity and Good Samaritan laws.
8. Educating first responders regarding the existence and operation of immunity and Good Samaritan laws.
9. Syringe service programs and other evidence-informed programs to reduce harms associated with intravenous drug use, including supplies, staffing, space, peer support services, referrals to treatment, fentanyl checking, connections to care, and the full range of harm reduction and treatment services provided by these programs.
10. Expanding access to testing and treatment for infectious diseases such as HIV and Hepatitis C resulting from intravenous opioid use.
11. Supporting mobile units that offer or provide referrals to harm reduction services, treatment, recovery supports, health care, or other appropriate services to persons that use opioids or persons with OUD and any co-occurring SUD/MH conditions.
12. Providing training in harm reduction strategies to health care providers, students, peer recovery coaches, recovery outreach specialists, or other professionals that provide care to persons who use opioids or persons with OUD and any co- occurring SUD/MH conditions.
13. Supporting screening for fentanyl in routine clinical toxicology testing.
PART THREE: OTHER STRATEGIES
I. F
IRST RESPONDERS
In addition to items in section C, D and H relating to first responders, support the following:
1. Education of law enforcement or other first responders regarding appropriate practices and precautions when dealing with fentanyl or other drugs.
2. Provision of wellness and support services for first responders and others who experience secondary trauma associated with opioid-related emergency events.
J. LEADERSHIP, PLANNING AND COORDINATION
Support efforts to provide leadership, planning, coordination, facilitations, training and technical assistance to abate the opioid epidemic through activities, programs, or strategies that may include, but are not limited to, the following:
1. Statewide, regional, local or community regional planning to identify root causes of addiction and overdose, goals for reducing harms related to the opioid epidemic, and areas and populations with the greatest needs for treatment
E-14
intervention services, and to support training and technical assistance and other strategies to abate the opioid epidemic described in this opioid abatement strategy list.
2. A dashboard to (a) share reports, recommendations, or plans to spend opioid settlement funds; (b) to show how opioid settlement funds have been spent; (c) to report program or strategy outcomes; or (d) to track, share or visualize key opioid- or health-related indicators and supports as identified through collaborative statewide, regional, local or community processes.
3. Invest in infrastructure or staffing at government or not-for-profit agencies to support collaborative, cross-system coordination with the purpose of preventing overprescribing, opioid misuse, or opioid overdoses, treating those with OUD and any co-occurring SUD/MH conditions, supporting them in treatment or recovery, connecting them to care, or implementing other strategies to abate the opioid epidemic described in this opioid abatement strategy list.
4. Provide resources to staff government oversight and management of opioid abatement programs.
K. TRAINING
In addition to the training referred to throughout this document, support training to abate the opioid epidemic through activities, programs, or strategies that may include, but are not limited to, those that:
1. Provide funding for staff training or networking programs and services to improve the capability of government, community, and not-for-profit entities to abate the opioid crisis.
2. Support infrastructure and staffing for collaborative cross-system coordination to prevent opioid misuse, prevent overdoses, and treat those with OUD and any co- occurring SUD/MH conditions, or implement other strategies to abate the opioid epidemic described in this opioid abatement strategy list (e.g., health care, primary care, pharmacies, PDMPs, etc.).
L. RESEARCH
Support opioid abatement research that may include, but is not limited to, the following:
1. Monitoring, surveillance, data collection and evaluation of programs and strategies described in this opioid abatement strategy list.
2. Research non-opioid treatment of chronic pain.
3. Research on improved service delivery for modalities such as SBIRT that demonstrate promising but mixed results in populations vulnerable to opioid use disorders.
E-15
4. Research on novel harm reduction and prevention efforts such as the provision of fentanyl test strips.
5. Research on innovative supply-side enforcement efforts such as improved detection of mail-based delivery of synthetic opioids.
6. Expanded research on swift/certain/fair models to reduce and deter opioid misuse within criminal justice populations that build upon promising approaches used to address other substances (e.g., Hawaii HOPE and Dakota 24/7).
7. Epidemiological surveillance of OUD-related behaviors in critical populations, including individuals entering the criminal justice system, including, but not limited to approaches modeled on the Arrestee Drug ADAM
8. Qua
litative and quantitative research regarding public health risks and harm reduction opportunities within illicit drug markets, including surveys of market participants who sell or distribute illicit opioids.
9. Geospatial analysis of access barriers to MAT and their association with treatment engagement and treatment outcomes.
City of Hesperia
STAFF REPORT
DATE: January 18, 2022
TO: Mayor and Council Members
FROM: Nils Bentsen, City Manager
BY: Rachel Molina, Assistant City Manager
Casey Brooksher, Director of Administrative Services
Mike Thornton, City Engineer
Ryan Leonard, Senior Planner
SUBJECT: Captial Improvement Project Prioritization
RECOMMENDED ACTION
It is recommended that the City Council receive and file this report.
BACKGROUND
At the December 21, 2021 City Council Meeting, the City Council requested an item be agendized for a presentation on Capital Improvement Project (CIP) prioritization along the freeway corridor and Main Street. I t was requested that the presentation include information about land -use designations along the freeway corridor north of Main Street, as well as information about proposed freeway interchanges. The information presented herein is for General Fund projects and does not include CIP projects for the Hesperia Water District.
Eucalyptus Interchange
In 2005, the City of Hesperia and City of Victorville jointly funded the preparation of a Project Study Report/Project Development Study, which was the first phase study report needed to justify a new interchange at this location. In 2005, 2006, and 2007, the Eucalyptus Interchange was included in the City’s Legislative Priorities document and federal funding had been requested. In 2007, the City of Victorville’s repre sentative to the local transportation authority reversed their support of the project in favor of the Nisqualli/La Mesa Interchange.
After Victorville withdrew their support, it was determined that this project was infeasible and the City redirected efforts to other areas of need, including the Ranchero and Muscatel Interchanges.
In the 15 years since the Eucalyptus Interchange Project Study has been completed, transportation and circulation needs, as well as proposed development have shifted markedly.
The 2007/2008 recession, the changes in online shopping habits of consumers, and the influx in residential development throughout the west side of Hesperia have contributed to staff identifying other alignments of priority over Eucalyptus. For these reasons, City staff no longer recommends prioritization of this improvement.
Muscatel Interchange
In 2007, p rioritization shifted from the Eucalyptus Interchange to the Muscatel Int erchange.
Located between Ranchero Road and Main Street, this site is entirely within the City of Hesperia jurisdiction. The location was deemed to be desirable because of the proximity to housing on the
Staff Report to the Mayor and Council Members
CIP Prioritization on Freeway Corridor and Main Street
January 18, 2022
west side, as well as the being conveniently located along a vital commercial corridor. With the subsequent recession, this project was reprioritized in the budget in favor of the Ranchero Corridor Projects. There is currently no funding identified for engineering or construction of this project.
Mojave Street Interchange
The proposed Mojave Street Interchange is located approximately 1 mile south of the Eucalyptus Street Interchange. The current land uses surrounding the Mojave Street Interchange consist primarily of vacant land. The existing Sou thern California Edison power line runs in a northwest to southeast direction and crosses Mojave Street approximately 700 feet west of the 15 freeway.
The General Plan Land Use Map designates the north and south side of Mojave Street as Regional Commercial (RC). There is currently no funding identified for engineering or construction of this project.
Alternative Interchange Alignments
Because of the aforementioned changes to circulation needs directly related to the patterns of development across the Hesperia, a preferred alternative interchange alignment of Mesa Street, between Main Street and Bear Valley, is in preliminary discussions; funding to study alternate alignments has not been identified. It should be noted that this alternative is not identified in the City’s Circulation Element of the General Plan.
As alternative alignments are discussed, important considerations have continued to include:
increased interest in residential development north of Main Street and the resulting traffi c congestion. Additionally, plans for the construction of a hospital and potentially a trauma center on the west side of Interstate 15 (I-15) between Main Street and Bear Valley Road are being considering with respect to alternate alignments that b est meet the needs of Hesperia residents and businesses.
Main Street Widening and Aqueduct Bridge Construction Project To improve circulation, Main Street will be widened from the I -15 freeway to Eleventh Avenue from four lanes to six lanes with center turn lanes and an additional aqueduct bridge adjacent to the existing bridge will be constructed consistent with the California Department of Water Resources (DWR) bridge requirements. The widening will achieve the ultimate configuration of Main Street which is classified as a Major Arterial Roadway in the City’s Circulation Element of the General Plan. This Project is identified on the San Bernardino County Transportation Authority (SBCTA) 10-year plan for projects the City intends to construct in the next decad e. The City is responsible for nearly 59% of the project costs, with SBCTA providing the remainder of the funding. This project is considered one of the City’s highest priority project, as identified in the City Council adopted 2021 Legislative Priorities document.
Other Capital Improvement Project Priorities
There are several priority projects in Hesperia for which funding is needed, including:
I Avenue Corridor Enhancement Plan –estimated project costs $53 million Sultana, Muscatel, and Cedar Street Improvements – estimated project costs $21.4 million Bear Valley Road Rehabilitation – estimated project costs $3.8 million North-South Corridor Improvements Study – estimated project costs $0.5 million Traffic Signal Installation at two intersections – estimated project costs $1.3 million
Staff Report to the Mayor and Council Members
CIP Prioritization on Freeway Corridor and Main Street
January 18, 2022
Additional information on these projects will be included in the 2022 Legislative Priorities document presented for City Council consideration in February 2022.
ISSUES/ANALYSIS
Funding Considerations
Project fundin g remains an obstacle to the design and construction of Capital Improvement Projects. The estimated project cost for each Freeway Interchange Project is $60 million. For the Main Street Project Widening and Aqueduct Bridge Project, the total project cost is $18.9 million for Main Street widening and $10.1 million for aqueduct bridge construction. The City intends to deliver the project in three (3) phases with each phase totaling about $10 million.
In April 2014, the City entered into an $18,762.403 variable interest loan from San Bernardino County Transit Authority (SBCTA) for the construction of the Ranchero Road Interchange, with the first annual payment due March 2019. The City committed its transportation Developer Impact Fees (DIF) to pay the annual principal amount is $1,876,240. It should be noted that the interest on the loan is determined by the Local Agency Investment Fund (LAIF). LAIF is an investment portfolio maintained by the State Controller and where the City currently invests its funds.
As of July 01, 2021, the City owes $13,133,682 on the loan and has seven years remaining of the ten-year note (final payment due during March 2028). With the current transportation DIF rate of $9,952 per single family residential (SFR) unit, the City will need 189 homes built annually to meet the debt service requirement. Over the course of seven years, this equates to approximately 1,300 homes.
The following table details the actual SFR permits received and the amount available a fter the debt service is factored:
FISCAL IMPACT
There is no fiscal impact associated with this discussion.
ATTACHMENT(S)
None
2019-20 2020-21
2021-22
Budget
Annual SFR Permits 239 295 300
Needed for Debt Service 189 189 189 Remaining for DIF Prefects 50 106 111 Dollar Value of Project 497,600 $ 1,054,912 $ 1,104,672 $ Cumulative 497,600 $ 1,552,512 $ 2,657,184 $
Notes:
1 -DIF is identified as funding source for the Ranchero Road Project